BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Nov 15, 2026; 18(11): 123857
Published online Nov 15, 2026. doi: 10.4251/wjgo.123857
Table 1 Basic patient characteristics and short-term efficacy, n (%)
Characteristic
Overall (n = 181)
FOLFOX (n = 68)
P-SOX (n = 113)
Statistic
P value1
Ageχ2 = 0.020.894
0100 (55.2)38 (55.9)62 (54.9)
181 (44.8)30 (44.1)51 (45.1)
Sexχ2 = 0.090.763
1151 (83.4)56 (82.4)95 (84.1)
230 (16.6)12 (17.6)18 (15.9)
cTχ2 = 0.280.868
240 (22.1)16 (23.5)24 (21.2)
392 (50.8)35 (51.5)57 (50.4)
449 (27.1)17 (25.0)32 (28.3)
cNχ2 = 0.050.825
055 (30.4)20 (29.4)35 (31.0)
1126 (69.6)48 (70.6)78 (69.0)
cTNMχ2 = 2.000.572
187 (48.1)37 (54.4)50 (44.2)
221 (11.6)6 (8.8)15 (13.3)
333 (18.2)11 (16.2)22 (19.5)
440 (22.1)14 (20.6)26 (23.0)
ASAχ2 = 0.390.530
0153 (84.5)56 (82.4)97 (85.8)
128 (15.5)12 (17.6)16 (14.2)
Differentiationχ2 = 0.280.871
150 (27.6)18 (26.5)32 (28.3)
253 (29.3)19 (27.9)34 (30.1)
378 (43.1)31 (45.6)47 (41.6)
RECIST 11χ2 = 1.600.206
077 (42.5)33 (48.5)44 (38.9)
1104 (57.5)35 (51.5)69 (61.1)
TRGχ2 = 1.160.281
051 (28.2)16 (23.5)35 (31.0)
1130 (71.8)52 (76.5)78 (69.0)
Tumor diameterχ2 = 4.570.102
173 (40.3)34 (50.0)39 (34.5)
268 (37.6)20 (29.4)48 (42.5)
340 (22.1)14 (20.6)26 (23.0)
Locationχ2 = 0.350.839
141 (22.7)14 (20.6)27 (23.9)
273 (40.3)29 (42.6)44 (38.9)
367 (37.0)25 (36.8)42 (37.2)


Write to the Help Desk